Suite 331-333 — Johnston, Rhode Island

Suite 331-333 is a clinical research site located in Johnston, Rhode Island, United States 02919.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Suite 331-333 has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Johnston

Browse all research sites in Rhode Island · View every site in Johnston

• Clinical Partners
• Research Site
• GSK Investigational Site
• Novartis Investigative Site
• Study Site 345
• Local Institution
• Foamix Investigational Site # 105
• Arcutis Clinical Site 101
• Forest Investigative Site 1144
• Dermavant Investigative Site
• Vanda Investigational Site
• Galderma Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Suite 331-333?

Suite 331-333 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Suite 331-333 conducted?

Suite 331-333 has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is Suite 331-333 accredited by Crixeo Clinical Trials?

Suite 331-333 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Suite 331-333?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.